Citation: Ka. Iseminger et Ma. Lewis, ETHICAL CHALLENGES IN TREATING MOTHER AND FETUS WHEN CANCER COMPLICATES PREGNANCY, Obstetrics and gynecology clinics of North America, 25(2), 1998, pp. 273
Authors:
BROUN ER
ISEMINGER KA
ROSE PG
LENTZ SL
MALFETANO JH
LINCOLN S
MANNEL R
Citation: Er. Broun et al., A PHASE-II TRIAL OF EDATREXATE IN PREVIOUSLY TREATED SQUAMOUS-CELL CERVICAL-CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 20(1), 1997, pp. 78-80
Authors:
MARKMAN M
ISEMINGER KA
HATCH KD
CREASMAN WT
BARNES W
DUBESHTER B
Citation: M. Markman et al., TAMOXIFEN IN PLATINUM-REFRACTORY OVARIAN-CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP ANCILLARY REPORT, Gynecologic oncology, 62(1), 1996, pp. 4-6
Citation: Er. Broun et al., A PHASE-II TRIAL OF EDATREXATE IN PREVIOUSLY TREATED OVARIAN-CANCER -A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 18(2), 1995, pp. 164-166